Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0002 Transporter Info | ||||
| Gene Name | ABCC2 | ||||
| Transporter Name | Multidrug resistance-associated protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Bosentan Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 104865 | ||||
| Docking Score | -8.361 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C27H29N5O6S | ||||
| Molecular Weight | 551.6 | ||||
| Canonical SMILES |
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
|
||||
| InChI |
InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)
|
||||
| InChIKey | GJPICJJJRGTNOD-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.8 | Rotatable Bond Count | 11 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 11 | ||
| Xenobiotic Name | Curcumin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 969516 | ||||
| Docking Score | -8.095 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H20O6 | ||||
| Molecular Weight | 368.4 | ||||
| Canonical SMILES |
COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O
|
||||
| InChI |
InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+
|
||||
| InChIKey | VFLDPWHFBUODDF-FCXRPNKRSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.2 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Lansoprazole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3883 | ||||
| Docking Score | -8.02 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H14F3N3O2S | ||||
| Molecular Weight | 369.4 | ||||
| Canonical SMILES |
CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
|
||||
| InChI |
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
|
||||
| InChIKey | MJIHNNLFOKEZEW-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.8 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 8 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.